Prevalence of the metabolic syndrome in an unorganized population taking into account different criteria of its diagnosis

Cover Page

Cite item

Full Text

Abstract

Aim. To study the prevalence of metabolic syndrome in an unorganized population of Orenburg city. Methods. The sample was formed by the method of random numbers. Examined were 301 people aged 25 to 75 years, of which 148 were males and 153 females. Studied were the socio-demographic characteristics and medical history (including filling out of a questionnaire), the clinical status of study participants (with the measurement of blood pressure, height, weight, waist and hip circumference, biochemical blood analysis to determine the concentration of glucose and lipid profile). In order to identify the metabolic syndrome the following diagnostic criteria were used: of the Work Group on the treatment of adults of the National Cholesterol Education Program of the U.S. (2001-2005), of the International Diabetes Federation (2005) and of the All-Russian Scientific Society of Cardiology (2009). Results. The prevalence of abdominal obesity was reduced by using less stringent thresholds for waist circumference. The most common variant of the metabolic syndrome was the combination of the following components: abdominal obesity, arterial hypertension and a low content of high-density lipoproteins. According to the criteria of the International Diabetes Federation such a combination occurred in 7.6%, while in accordance with the Criteria of the Work Group on for the treatment of adults of the National Cholesterol Education Program of the U.S. - it occurred in 4.3%. Conclusion. The frequency of registration of the metabolic syndrome depends on the criteria for its diagnosis.

About the authors

E N Isaeva

Orenburg State Medical Academy, Orenburg, Russia

Email: isaeva.com@mail.ru

References

  1. Оганов Р.Г. Концепция факторов риска как основа профилактики сердечно-сосудистых заболеваний // Врач. - 2001. - Т. 7. - С. 3-6.
  2. Cuspidi C., Meani S., Fusi V. et al. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study // J. Hypertens. - 2005. - Vol. 23. - P. 875-882.
  3. Kavamoto R., Tomita H., Oka Y. et al. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis // Intern. med. - 2005. - Vol. 44. - P. 1232-1238.
  4. Lakka H.M., Laaksonen D.E., Lakka T.A. et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men // JAMA. - 2002. - Vol. 288. - P. 2709-2716.
  5. Mancia G., Bombelli M., Corrao G. et al. Metabolic syndrome in the Pressioni Arteriose Monitorate E. Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis // Hypertension. - 2007. - Vol. 49. - P. 40-47.
  6. Mule G., Nardi E., Cottone S. et al. Influence of metabolic syndrome on hypertension-related target organ damage // J. Intern. Med. - 2005. - Vol. 257. - P. 503-513.
  7. Reaven G. Role of insulin resistance in human disease // Diabetes. - 1988. - Vol. 37 - P. 1595-1520.
  8. Resnick H.E., Hones K., Ruotolo G. et al. Insulin resistance, the metabolic syndrome, and of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study // Diabetes Care. - 2003. - Vol. 26. - P. 861-867.
  9. Schilacci G., Pirro M., Vaudo G. et al. Meabolic syndrome is associated with aortic stiffness in untreated essential hypertension // Hypertension. - 2005. - Vol. 45. - P. 1978-1982.
  10. Schmidt M.I., Duncan B.B., Bang H. et al. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study // Diabetes Care. - 2005. - Vol. 28. - P. 2013-2018.
  11. Vasan R.S., Beiser A., Seshadri S. et al. Residual lifetime risk for developing hypertension in middle-aged women and men. The Framingham Study // JAMA. - 2002. - Vol. 287. - P. 1003-1010.

© 2012 Isaeva E.N.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies